Antiproteinuric effect of add-on paricalcitol in CKD patients under maximal tolerated inhibition of renin-angiotensin system: a prospective observational study
© De Nicola et al.; licensee BioMed Central Ltd. 2012
Received: 16 July 2012
Accepted: 18 November 2012
Published: 20 November 2012
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|16 Jul 2012||Submitted||Original manuscript|
|20 Aug 2012||Reviewed||Reviewer Report - Nobuo Tsuboi|
|23 Sep 2012||Reviewed||Reviewer Report - Andrew Frankel|
|29 Sep 2012||Reviewed||Reviewer Report - Kresimir Galesic|
|30 Oct 2012||Author responded||Author comments - Luca De Nicola|
|Resubmission - Version 2|
|30 Oct 2012||Submitted||Manuscript version 2|
|31 Oct 2012||Reviewed||Reviewer Report - Nobuo Tsuboi|
|8 Nov 2012||Reviewed||Reviewer Report - Kresimir Galesic|
|Resubmission - Version 3|
|Submitted||Manuscript version 3|
|18 Nov 2012||Editorially accepted|
|20 Nov 2012||Article published||10.1186/1471-2369-13-150|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.